AVH 6.30% $2.53 avita medical inc.

just a note from previous fin report..."Revenues from the sale...

  1. 811 Posts.


    just a note from previous fin report...

    "Revenues from the sale of ReCell rose by 61% in FY11 compared to FY10"

    Also note that during the last quarter we had the following:

    Sep 11 - JV in Middle East and Africa

    Oct 11 - launch of treatment of chronic ulcers

    Dec 11 - Expansion into Italy

    So alot more to come yet and I'm expecting an exponential rise in saes as new geographic JV's take hold.

    All good

    maddoc
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.